SCHEMBL27769032

SCHEMBL27769032

Cc1ccccc1N1CCC(Oc2ncnc(Oc3ccc(S(C)(=O)=O)cc3F)c2C)CC1

nearest known ligand 0.65

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 18/20 0.65
CYP2C9 P11712 1/20 0.65
GPR6 P46095 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5046636 0.88 GPR119 (0.59) GPR119CYP2C9GPR6
SCHEMBL1899893 0.87 GPR119 (0.63) GPR119CYP2C9GPR6
SCHEMBL5188918 0.87 GPR119 (0.64) GPR119CYP2C9GPR6
SCHEMBL2786447 0.83 GPR119 (0.79) GPR119CYP2C9
SCHEMBL5188908 0.82 GPR119 (0.58) GPR119CYP2C9
SCHEMBL390199 0.82 GPR119 (0.62) GPR119CYP2C9
SCHEMBL1890890 0.81 GPR119 (0.66) GPR119CYP2C9
SCHEMBL387832 0.80 GPR119 (0.65) GPR119CYP2C9
SCHEMBL388755 0.80 GPR119 (0.65) GPR119CYP2C9
SCHEMBL387984 0.80 GPR119 (0.65) GPR119CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101420941-A Use of GPR119 receptor agonists for increasing bone mass and for treating osteoporosis, and related combination therapies ARENA PHARM INC (US) 2009-04-29 CN disclosed